AstraZeneca to Invest $245 Million in Cellectis for Gene Therapy Advancements on November 01, 2023 AstraZeneca Biotech Cellectis Gene Editing Gene Therapy Healthcare News. Investment Pharmaceutical Industry +
FDA Approves Novartis Drug Cosentyx for Hidradenitis Suppurativa Treatment on November 01, 2023 Autoimmune Disorder Biologic Treatment Clinical Trials Cosentyx FDA Healthcare News. Hidradenitis Suppurativa Inflammatory Diseases Novartis Skin Condition +